Antibe Therapeutics Inc(Pre-Merger) T.ATE

Antibe Partnership to Accelerate Drug Pipeline

[mstrmnd]

Based on quality of data from existing studies, I would not be surprised if Antibe partnered with Big Pharma earlier than expected to accelerate entire drug pipeline

Antibe can conduct multiple Phase 3 clinical trials with their pipeline simultaneously with a pharma partner - Antibe took 7 years to get ATB-346 here, with a pharma partner, all 4 of their top patents can be accelerated into their respective markets

GLTA

[MrMugsy]

That certainly is one potential angle and I'd welcome it. But - I see a required path in order to open that up to us. 346(acute) seems to be straight forward. 352(acute) to also follow suit  - but -  we don't know the specific purpose intended for that drug (yet). Then - the rest of the pipeline is what we'd call "long term" or chronic type indications (for the

[mstrmnd]

If you have an IND/DIN for oral treatment of acute pain, it's natural progression to go to chronic pain thereafter There's absolutely no need to do dose ranging for chronic pain pre-partnership, otherwise could burn through cash when #1 priority IND/DIN is Post-Operative Pain for Otenaproxesul After successful Phase 2 in Post-Operative Pain, Antibe will have very successul efficacy and

[MrMugsy]

If ATE can move acute pain medications to chronic indications (which I get the white-label approach), why have they spent over a million dollars on liver specialists?  Dan says they are prepared to spend more to find an OA solution. Why waste time here ? “The Company is investigating alternative dosing regimens as a potential path forward for chronic indications.” Would this go above and

[mstrmnd]

They need to have clarity that chronic indications are feasible but do not necessarily need to conduct large clinical trials for chronic use in OA until a partnership.  It's best to have as much cash as possible for negotiations and firm up chronic use in cost-effective means.   This is why the position of the company has now entirely changed.  When you're an acute

[StockingUp21]

crzymnd, if partnerships were happening it would by now before we learned the liver issue. 

[fox7mf]

A buyout/takeover right now or soon would not, I believe, get us what most of us want for Antibe. How much could they possibly ask for the pipeline at the moment or in the next 6-12 months?

[mstrmnd]

They are looking to get at least $1B for Otenaproxesul.  This is the entry point for any player to take it.  No point selling less, it's worth more.